Hjem › Lupus-nefritt › California
Kliniske studier for Lupus-nefritt i California
15 studier for Lupus-nefritt søker deltakere på steder i California.
Byer i California
Offisiell studietekst (engelsk)
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Ronald Reagan UCLA Medical Center, Los Angeles
RekruttererFase 2
Alder 18 til 100 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT05268289VIBRANT: VIB4920 for Active Lupus Nephritis
- University of California San Diego School of Medicine: Division of Rheumatology, Allergy and Immunology, La Jolla
- UCLA Medical Center: Division of Rheumatology, Los Angeles
- of California, Irvine School of Medicine Division of Rheumatology, Orange
- og 1 flere
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT05201469Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
- University of California San Francisco - Zuckerberg San Francisco General, San Francisco
RekruttererFase 1
Alder 18 til 60 · Alle kjønn · Oppdatert 14. sep. 2026 · NCT06975787The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
- University of California, San Francisco, San Francisco
RekruttererFase 2
Alder 8 til 20 · Alle kjønn · Oppdatert 14. sep. 2026 · NCT05538208A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
- Wallace Rheumatic Studies Center, Beverly Hills
- Kaiser Permanente Fontana, Fontana
- Providence Medical Foundation, Fullerton
- og 2 flere
RekruttererFase 2
Alder 12 til 70 · Alle kjønn · Oppdatert 14. sep. 2026 · NCT07570862A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- Research Site, San Francisco
- Research Site, Stanford
RekruttererFase 1/2
Alder 18 til 70 · Alle kjønn · Oppdatert 10. sep. 2026 · NCT06897930A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Loma Linda University Medical Center, Loma Linda
RekruttererFase 1
Alder 18 til 74 · Alle kjønn · Oppdatert 10. sep. 2026 · NCT07085104A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
- Loma Linda University health, Loma Linda
- UCSF Benioff Childrens Hospital, San Francisco
RekruttererFase 2
Alder 5 til 17 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT05039619A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- UC San Diego Health, La Jolla
- Stanford University Medical Center, Redwood City
RekruttererFase 1
Alder 18 til 70 · Alle kjønn · Oppdatert 28. aug. 2026 · NCT06925542RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- University of California Irvine, Orange
- UC Davis Health, Sacramento
RekruttererFase 1/2
Alder 18 til 65 · Alle kjønn · Oppdatert 26. aug. 2026 · NCT06121297PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
- Purushotham & Akther Kotha MD, Inc., La Mesa
- Valerius Medical Group & Research Center of Greater Long Beach, Inc., Los Alamitos
RekruttererFase 4
Alder 18 til 75 · Alle kjønn · Oppdatert 3. aug. 2026 · NCT07611214A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
- Nkarta Investigational Site, Tustin
RekruttererFase 1/2
Alder 18 til 75 · Alle kjønn · Oppdatert 4. jun. 2026 · NCT06557265A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Wallace Rheumatic Center, Beverly Hills
- Providence Medical Foundation, Fullerton
- University of California Irvine, Irvine
- og 2 flere
RekruttererFase 1
Alder 12 til 70 · Alle kjønn · Oppdatert 22. mai 2026 · NCT06308978Lupus Landmark Study: A Prospective Registry and Biorepository
- Wallace Rheumatic Studies Center, Beverly Hills
- UCLA, Los Angeles
RekruttererObservasjonsstudie
Alder 18 til 110 · Alle kjønn · Oppdatert 15. apr. 2026 · NCT05934149Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor
- Lucile Packard Children's Hospital, Palo Alto
RekruttererFase 1/2
Alder 1 til 30 · Alle kjønn · Oppdatert 17. jul. 2023 · NCT05508009Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.